First Time Loading...
S

Santhera Pharmaceuticals Holding AG
SIX:SANN

Watchlist Manager
Santhera Pharmaceuticals Holding AG
SIX:SANN
Watchlist
Price: 9.25 CHF -0.96% Market Closed
Updated: May 21, 2024

Santhera Pharmaceuticals Holding AG
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Santhera Pharmaceuticals Holding AG
Pre-Tax Income Peer Comparison

Comparables:
ADCT
CRSP
BSLN
IDIA
KURN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Santhera Pharmaceuticals Holding AG
SIX:SANN
Pre-Tax Income
CHf54.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Pre-Tax Income
-$195.4m
CAGR 3-Years
7%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Pre-Tax Income
-$214.8m
CAGR 3-Years
18%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Basilea Pharmaceutica AG
SIX:BSLN
Pre-Tax Income
CHf10.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Idorsia Ltd
SIX:IDIA
Pre-Tax Income
-CHf820.1m
CAGR 3-Years
-19%
CAGR 5-Years
-122%
CAGR 10-Years
N/A
Kuros Biosciences AG
SIX:KURN
Pre-Tax Income
-CHf13.3m
CAGR 3-Years
-3%
CAGR 5-Years
1%
CAGR 10-Years
N/A

See Also

What is Santhera Pharmaceuticals Holding AG's Pre-Tax Income?
Pre-Tax Income
54.8m CHF

Based on the financial report for Dec 31, 2023, Santhera Pharmaceuticals Holding AG's Pre-Tax Income amounts to 54.8m CHF.